Trends and persistent disparities in incidence, mortality, and survival of pancreatic cancer: A Surveillance, Epidemiology, and End Results program–based retrospective cohort study (2000–2021). This ...

NET as a potentially important new option for NET patients. Perspective Therapeutics, Inc. (NYSE:CATX) will discuss these ...

Several AON physicians and leaders shared new cancer research at one of oncology’s most influential gatheringsFORT MYERS, Fla ...

Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs") today announced the presentation of groundbreaking clinical data from a multicenter phase Ib/II clinical trial evaluating LBL-024, an anti-PD-L1/4-1BB ...

Oral presentation of CARTITUDE-1 study data showcases long-term outcomes after a single infusion of CARVYKTI ® with one-third of patients with relapsed/refractory multiple myeloma progression-free for ...

(UroToday.com) The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, held in Chicago, IL, was host to a kidney and bladder cancers oral abstract session. Dr. Tian Zhang discussed the ...

Bildnachweis: ITM Isotope Technologies Munich SE, VC Magazin, Pixabay. As the global demand for targeted cancer therapies ...

“Grade 2 fatty liver disease” is the term for moderate fatty liver disease and its symptoms. Fatty liver disease results from excessive buildup of fat in the liver. Medical professionals may ...

T1 Tumor limited ... neuroendocrine tumors in the future. Peptide receptor radiotherapy is a new treatment option for patients with high tumor content of somatostatin type 2 receptors and will ...

Neuroendocrine colon cancer is a rare and aggressive form of cancer that starts in the cells of the colon with both nerve and ...

The genetic makeup and structure of glioblastoma tumors can shift dramatically across different regions of a single tumor, ...

Two studies reveal promising treatments for breast cancer, enhancing options for patients with triple-negative breast cancer ...